Cancer Immunology, 2nd Edition, (PDF) describes the immunology of organ-particular malignancies and discusses novel immunotherapy methods for their remedy. After the primary, very profitable version of the ebook was revealed in 2015, a lot of fully new chapters have been included. The vary of cancers regarded has accordingly been prolonged, with the inclusion of the newest immunotherapy approaches for cancers in several organs. Moreover, the unique chapters have been up to date to doc the newest advances in immunotherapy for pediatric stable tumors, gastrointestinal tumors, bone tumors, hematologic malignancies, central nervous tumors, genitourinary tract tumors, lung most cancers, and breast most cancers, amongst others. The ebook is revealed as a part of the three-quantity Springer sequence Cancer Immunology, which goals to supply an up-to-date, clinically related assessment of most cancers immunology and immunotherapy. Other volumes within the sequence tackle the translational drugs context and bench-to-bedside immunotherapy. Cancer Immunology: Cancer Immunotherapy for Organ-Specific Tumors can be of particular worth to medical hematologists, immunologists, and oncologists. NOTE: The product only contains the ebook Cancer Immunology 2nd Edition in PDF. No access codes are included.
Cancer Immunology: Cancer Immunotherapy for Organ-Specific Tumors (2nd Edition) – PDF
eBook Details
- Author: Nima Rezaei
- File Size: 12 MB
- Format: PDF
- Length: 600 Pages
- Publisher: Springer; 2nd edition
- Publication Date: December 12, 2020
- Language: English
- ASIN: B08QGLNN78
- ISBN-10: 3030579492, 3030579484
- ISBN-13: 9783030579494, 9783030579487
Original price was: $237.49.$19.00Current price is: $19.00.
About The Author
Nima Rezaei
Dr. Nima Rezaei is an Iranian scientist who works at Tehran University of Medical Sciences as a professor of clinical immunology and allergy, Associate Dean of International Affairs in the School of Medicine, and Director of the Global Academic Program (GAP). Nima Rezaei is the brains behind the Universal Scientific Education and Research Network, as well as its creator and current president (USERN).
Rezaei is well-known for his work on the characterisation and treatment of primary immunodeficiencies.
Under the guidance of Professor Asghar Aghamohammadi, he founded the Iranian Primary Immunodeficiency Diseases Registry (IPIDR) in 1999, which won him the best scientific project prize at the 4th Avicenna festival.
Reviews
There are no reviews yet.